about
Predicted protein interactions of IFITMs which inhibit Zika virus infectionThe Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and ReleaseSolute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesPrinciples of Virus Uncoating: Cues and the Snooker BallZika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.Accurate characterization of the IFITM locus using MiSeq and PacBio sequencing shows genetic variation in GalliformesRhesus macaque IFITM3 gene polymorphisms and SIV infection.IFITM3 Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population.Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference.A membrane topology model for human interferon inducible transmembrane protein 1.IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells.IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza VirusesMolecular determinants of the ratio of inert to infectious virus particles.Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.Interferon-Induced Transmembrane Protein 3 Inhibits Hantaan Virus Infection, and Its Single Nucleotide Polymorphism rs12252 Influences the Severity of Hemorrhagic Fever with Renal Syndrome.IFITM3 requires an amphipathic helix for antiviral activity.Lipid interactions during virus entry and infection.IFITM1 suppresses expression of human endogenous retroviruses in human embryonic stem cells.IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cellsThe V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection.Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication.JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1.Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.Alphavirus Restriction by IFITM ProteinsBat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses.Fuse me IFITM can!More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins.Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation.Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.Recent advances in antiviral interferon-stimulated gene biology.Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3
P2860
Q26247786-0857A95D-5C7D-400E-8109-3990D8FEB63BQ26700101-0418ED21-A713-4825-88E2-C338E7651DB5Q27928046-36B834BC-3D28-4AAB-9FA3-4C966A0FB9CAQ28074854-36DE43D6-B5F6-41BB-B32D-407B172EF694Q30145650-1B90652A-837F-4BA9-ABE7-850FC35AE93FQ30250922-12DAA8E7-854A-4699-8899-6365C2165B8AQ30361340-DA2BA6DA-9DA3-4658-A745-DE492FC45743Q33854786-7CCC58BE-6FD6-43D3-AA12-978DD442239DQ34627384-A675FA01-2026-4A33-8A98-ACA4B18174AAQ35182009-7C209C99-88D9-46BC-A447-B97D0AE20E2EQ35221778-3722374B-03FD-4B08-BB75-331D4B6FAFB8Q35808675-59A05CC1-14A9-4891-90D5-0B0A17D01FBAQ36150469-4CA1139B-6876-4258-83C0-41F6EAE8B4B9Q36433944-D36FE50F-6D35-43E4-AF1B-6D5ACA2B7981Q36494676-7ABCB841-A0FC-4809-8329-862376ADB03EQ36765053-0B6D16B5-7552-405E-A090-B1672F42D888Q37359047-AF33B9B1-B707-4C57-BF3D-484B2D6D5BF0Q37550098-A4E666AF-61BA-4CEF-89A9-B8BFFD295996Q38156590-C7C41C88-5BFD-4CFD-AD6F-98140110710CQ38240675-C18DBB7D-6827-4D24-9B94-36479E906EB2Q38637849-5763EADF-9048-423C-9DD2-593243B38951Q38707618-1E818762-EFB2-4EA8-9D53-4E5D6B376116Q38746434-13CC6B74-983F-42C4-86B9-FACFE2E69950Q39013830-86442945-2E66-4D94-A7C2-2B46F041FB51Q39076009-5B240AD5-7596-4242-AF87-262E32A5B5B5Q39717911-21988064-CF59-40B1-BC53-0AB53E3F0F16Q40331435-624B5BDC-4998-4D2D-9326-1009E32C14EEQ40469216-F14B1029-208D-4255-9A11-FFB7411CF534Q40661847-89565F27-7CC4-4EC3-9B88-389C67FE8B98Q41525616-3849CE92-EED6-4948-A3FC-29399C2D7114Q41649698-FC484A35-C59F-4757-96F2-655E333836F5Q46197224-B0DE5517-E5A4-48F1-9920-4124EE1B0190Q47242824-8E8560AC-1453-40AD-96CA-945DB5C0A1F1Q47550785-B26BE8AC-171C-40D7-AB74-D16682C8EF4BQ52367862-BA07F097-DA15-4398-AFFD-0BE547FB1E2DQ54250434-873E6B3A-C63E-491F-9F83-0A62B3FA6E4EQ55122030-E13E12DA-4D26-46F4-8542-2DC3711C555CQ57292151-F94EAF82-028B-4D7B-9492-283A6E394857
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
IFITM proteins-cellular inhibitors of viral entry.
@en
type
label
IFITM proteins-cellular inhibitors of viral entry.
@en
prefLabel
IFITM proteins-cellular inhibitors of viral entry.
@en
P50
P1476
IFITM proteins-cellular inhibitors of viral entry
@en
P2093
P356
10.1016/J.COVIRO.2013.11.004
P577
2014-01-28T00:00:00Z